Stockscreener 앱 받기
53.32
0.43%
0.23
시장 영업 전:
53.02
-0.30
-0.56%
Gsk Plc Adr 주식(GSK)의 최신 뉴스
Price to earnings forward of GSK plc Sponsored ADR – MUN:GS70 - TradingView
GSKGSK Plc ADR Latest SEC Filings - Finviz
Big Pharma Has a Case of Merger Mania - The Motley Fool
GS70 Forecast — Price Target — Prediction for 2027 - TradingView
GSK Stock Quote Price and Forecast - CNN
Shareholder in GSK (NYSE: GSK) trims voting stake to 4.96% - Stock Titan
GSK to strengthen oncology pipeline with $10.6B Nuvalent buyout - MSN
Price to earnings forward of GSK plc Sponsored ADR – LS:A3DMHS - TradingView
A3DMHS Forecast — Price Target — Prediction for 2027 - TradingView
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
GSK (GSK) reports major holder crossing 5% voting rights threshold - Stock Titan
GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Actuals & Estimates (BCBA:GSKC) - TradingView
Why GSK's Shingrix is reshaping the shingles vaccine market - AD HOC NEWS
GSK PLC (GSK) Stock Price, Trades & News - GuruFocus
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs - Sahm
Here's Our Take On Theravance Biopharma Inc (NASDAQ:TBPH) and GlaxoSmithKline plc (ADR) (NYSE:GSK)'s Latest Submission - Yahoo Finance
GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder - TradingView
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal - Sahm
GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent - Sahm
GSK plc stock (GB0009252882): Nuvalent deal sharpens oncology focus - AD HOC NEWS
GSK to Strengthen Oncology Pipeline With $10.6B Nuvalent Buyout - TradingView
GSK to acquire cancer biotech Nuvalent in $10.6 billion deal - grafa.com
Why is Glaxo (GSK) down 2.1% since last earnings report? - MSN
GSK Bets on Specialty Medicines to Drive Long-Term Revenue Growth - TradingView
GSK plc (ADR) stock (GB0009252882): ADR treads water around mid-USD 50s as London shares retreat on - AD HOC NEWS
GSK plc (ADR) stock (GB0009252882): ADR holds steady as investors await next catalysts after recent - AD HOC NEWS
GSK Stock Price, Quote & Chart | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill
GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Revenue Breakdown – BCBA:GSK.CI - TradingView
GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Earnings and Revenue – BCBA:GSK.CI - TradingView
GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Balance Sheet – BCBA:GSK.CI - TradingView
GSK PLC-SPON ADR (NYSE:GSK) Passes Quality-Focused Caviar Cruise Stock Screener with Strong Profitability and Cash Flow - ChartMill
GSK plc stock (GB0009252882): buyback activity and Q1 update keep focus on vaccines and specialty me - AD HOC NEWS
1.48%
자본화:
|
볼륨(24시간):